Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Sudhir V. Shah's research interests encompass patient and public involvement in health research, with a focus on behavioral science and the translation of emerging technologies into clinical practice. He has extensive experience as a lay public and patient involvement (PPI) representative with the National Institute for Health Research (NIHR) Applied Research Collaborations (ARCs). Shah also serves as a member of an NIHR Patient Safety Translation Research Centre, where he reviews research studies and papers, particularly those addressing patient safety and behavioral science topics such as statin reluctance and other medication-related issues.
His work extends to co-production in health research, including participation in UCL's Co-Production Group (COG) for Loneliness and Social Isolation. In this capacity, he advises on research funding and promotes the group's principles. Shah is also a member of the Lived Experience Advisory Panel for Chronic Depression at the East London NHS Foundation Trust, contributing to the development of tools for patient and clinician input. Additionally, he is a member of the PPIE Strategy group at Newcastle University’s Policy Research Unit in Behaviour Science at Population Health Science.
Shah's scholarly output includes publications on topics such as the public perception of AI in clinical practice, the burden of rare genetic disorders, iron chelation's effects on age-related sarcopenia in mice, and advancements in CRISPR/Cas9 technology. His research metrics include an h-index of 68, over 321 publications, and more than 20,000 citations, designating him as a highly cited researcher. He leads a research group and collaborates with other faculty members at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 68
- Publications: 322
- Citations: 20,743
Selected Publications
-
Effectiveness and efficiency of an add-on active outreach strategy on research enrollments in a drug intervention trial (2025)
-
A simpler and more sensitive modified catalytic (bleomycin detectable) iron assay (2025)
-
Iron Chelation Prevents Age‐Related Skeletal Muscle Sarcopenia in Klotho Gene Mutant Mice, a Genetic Model of Aging (2025)
-
Ophthalmological Safety of Hydroxychloroquine in CKD (2023)
-
Vascular Function Indices Are Strong Predictors of the Severity and Characteristics of Carotid Atherosclerosis (2021)
-
Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design (2021)
Collaboration Network
Top Collaborators
- Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Supplementary Material for: Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Vascular Function Indices Are Strong Predictors of the Severity and Characteristics of Carotid Atherosclerosis
- Ophthalmological Safety of Hydroxychloroquine in CKD
- Patterns and Predictors of MRI-Based Atherosclerotic Burden in CKD: Baseline Analysis of the MaCK Study Participants
- Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Supplementary Material for: Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Vascular Function Indices Are Strong Predictors of the Severity and Characteristics of Carotid Atherosclerosis
- Ophthalmological Safety of Hydroxychloroquine in CKD
- Patterns and Predictors of MRI-Based Atherosclerotic Burden in CKD: Baseline Analysis of the MaCK Study Participants
- Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Supplementary Material for: Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Vascular Function Indices Are Strong Predictors of the Severity and Characteristics of Carotid Atherosclerosis
- Ophthalmological Safety of Hydroxychloroquine in CKD
- Patterns and Predictors of MRI-Based Atherosclerotic Burden in CKD: Baseline Analysis of the MaCK Study Participants
- Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Supplementary Material for: Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Patterns and Predictors of MRI-Based Atherosclerotic Burden in CKD: Baseline Analysis of the MaCK Study Participants
- A study of Acute Encephalitis Syndrome – Clinical profile, aetiology, and outcome
- Evaluation of drug-resistant focal epilepsy in the western Indian adult population
- Amyloid myopathy: A rare cause of quadreparesis with bulbar palsy
- Vascular Function Indices Are Strong Predictors of the Severity and Characteristics of Carotid Atherosclerosis
- Ophthalmological Safety of Hydroxychloroquine in CKD
- Patterns and Predictors of MRI-Based Atherosclerotic Burden in CKD: Baseline Analysis of the MaCK Study Participants
- Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Supplementary Material for: Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Supplementary Material for: Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Supplementary Material for: Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- Supplementary Material for: Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
- A study of Acute Encephalitis Syndrome – Clinical profile, aetiology, and outcome
- Evaluation of drug-resistant focal epilepsy in the western Indian adult population
- A study of Acute Encephalitis Syndrome – Clinical profile, aetiology, and outcome
- Evaluation of drug-resistant focal epilepsy in the western Indian adult population
- Iron Chelation Prevents Age‐Related Skeletal Muscle Sarcopenia in Klotho Gene Mutant Mice, a Genetic Model of Aging
- Catalytic (labile) iron in kidney disease
- Advancement in CRISPR/Cas9 Technology to Better Understand and Treat Neurological Disorders
- Pharmacological Strategies for Stroke Intervention: Assessment of Pathophysiological Relevance and Clinical Trials
- Advancement in CRISPR/Cas9 Technology to Better Understand and Treat Neurological Disorders
- Pharmacological Strategies for Stroke Intervention: Assessment of Pathophysiological Relevance and Clinical Trials
Similar Researchers
Based on overlapping research topics